Pancreatic Cancer Research

ResearcherBeijing University of Chinese MedicineActive in the last 2 years

Quanwang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-4186-0060; OpenAlex author ID A5050375104. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Gut microbiota, circulating metabolites, and pancreatic cancer risk: a multi-method causal inference study with cross-population validation. Last author DOI 10.3389/fmicb.2025.1730313↗
  2. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway. Co-author DOI 10.1016/j.jep.2024.117872↗
  3. Cinobufacini Inhibits the Development of Pancreatic Cancer Cells through the TGFβ/Smads Pathway of Pancreatic Stellate Cells. Co-author DOI 10.1155/2022/3719857↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chuanbo Liu · 1 shared paper, 2024 · strength 0.31
  2. Yuehui Wang · 1 shared paper, 2024 · strength 0.31
  3. Shicheng Lin · 1 shared paper, 2025 · strength 0.28
  4. Ke-Rui Zhang · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.